Genome Editing From Modeling Disease to Novel Therapeutics
The ability of human pluripotent stem cells (hPSCs) to differentiate into the many specialized cell types of the human body holds great promise for the study and treatment of human disease. Genome editing of hPSCs can allow for more accurate modeling of human diseases by introducing disease-specific mutations, or correct genetic aberrations in patient-derived induced pluripotent stem cell lines. Advances in tools such as transcription activator-like effector nucleases (TALENs) or clustered regularly interspaced short palindromic repeat (CRISPR) technologies have improved the ease and efficiency of genome editing in hPSCs.
Watch this free webinar featuring Dr. Chad Cowan (Harvard University) to learn how you can modify hPSC genomes and enhance the physiological relevance of your research.
Topics:
- Culture conditions for expansion and cloning of hPSCs
- Design and use of TALENs or CRISPRs with hPSCs
- Identification of clones without antibiotic selection
- Applications of modified hPSCs including disease modeling
- Use of the CRISPR/Cas system for gene therapy
Publish Date: June 20, 2014
Views: 0
Related Multimedia
-
Using CRISPR/Cas9 to Model Stem Cell Organization and Dynamics
Publish Date: August 25, 2017 -
Understanding Pancreatic Development and Diabetes Using Patient-Specific iPS Cells
Publish Date: April 18, 2016 -
Investigating Metabolic Disease with Human Pluripotent Stem Cells
Publish Date: May 13, 2016 -
Making Lung Cells from Pluripotent Stem Cells: Disease Modeling and Future Therapies
Publish Date: August 12, 2016
Explore Our Products
-
Matrix for maintenance of human ES and iPS cells in combination with TeSR™ maintenance media -
cGMP, feeder-free maintenance medium for human ES and iPS cells
